West Pharmaceutical Services (WST) revenue

Revenue · fiscal 2025
$3.07B

West Pharmaceutical Services (WST) reported revenue of $3.07B in fiscal 2025 (the year ended December 31, 2025). That is 6.3% higher than the $2.89B of fiscal 2024. Figures as of 18 Nov 2026, 08:20 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$3.07B
Change on fiscal 2024
+6.3%
Growth, 5 years
+7.4% a year
Growth, 10 years
+8.2% a year
Highest on record
$3.07Bfiscal 2025
Lowest on record
$1.05Bfiscal 2008
Fiscal years on record
182008–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

West Pharmaceutical Services revenue, in more detail

Over the five fiscal years to 2025 revenue grew at a compound 7.4% a year; over ten years the rate was 8.2% a year. Across the 18 fiscal years on record (2008–2025), the highest was $3.07B in fiscal 2025 and the lowest $1.05B in fiscal 2008.

History · 18 fiscal years

Revenue by fiscal year

West Pharmaceutical Services revenue, year by year

West Pharmaceutical Services (WST) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$3.07B 6.3% up
2024$2.89B 1.9% down
2023$2.95B 2.2% up
2022$2.89B 2.0% up
2021$2.83B 31.9% up
2020$2.15B 16.7% up
2019$1.84B 7.1% up
2018$1.72B 7.4% up
2017$1.60B 6.0% up
2016$1.51B 7.8% up
2015$1.40B 1.5% down
2014$1.42B 3.9% up
2013$1.37B 8.1% up
2012$1.27B 6.2% up
2011$1.19B 7.9% up
2010$1.10B 4.6% up
2009$1.06B 0.4% up
2008$1.05B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

Revenue at health care companies of similar size

Revenue of West Pharmaceutical Services and comparable companies
CompanyRevenueFiscal year
Labcorp Holdings LH$13.95B2025
DexCom DXCM$4.66B2025
Koninklijke Philips PHG€17.83B2025
Roivant Sciences ROIV$8.26M2026
West Pharmaceutical Services WST$3.07B2025
Quest Diagnostics DGX$11.04B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on WST

West Pharmaceutical Services, figure by figure

West Pharmaceutical Services (WST) overview: price, valuation and scorecardAll health care companies by market value

West Pharmaceutical Services revenue: questions and answers

What is West Pharmaceutical Services's revenue?

West Pharmaceutical Services (WST) reported revenue of $3.07B in fiscal 2025 (the year ended December 31, 2025). That is 6.3% higher than the $2.89B of fiscal 2024.

What is the growth rate of West Pharmaceutical Services's revenue?

Over the five fiscal years to 2025 revenue grew at a compound 7.4% a year; over ten years the rate was 8.2% a year.

What are the highest and lowest revenue figures on record for West Pharmaceutical Services?

Across the 18 fiscal years on record (2008–2025), the highest was $3.07B in fiscal 2025 and the lowest $1.05B in fiscal 2008.

How is West Pharmaceutical Services's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “West Pharmaceutical Services (WST) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/WST/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.